Chem-Biochem Home | UMBC Home | Directory | Apply (Free!) | myChem | Search 
CONTACT INFORMATION
Office: MEYR 107
Phone: 410-455-2520
Professional Interests
Publications
Honors/Awards
Funding
Courses Taught
Research Group
Ramachandra Hosmane
Professor
Ph.D. University of South Florida, Tampa 1978; M.S. University of South Florida 1976; Post-Doctoral University of Illinois at Urbana-Champaign 1979
FUNDING
Artificial Blood Based on Hemoglobin Dendrimers
American Heart Association
2007-2009
Mechanistic Studies of Anti-HIV Activity of a Ring-Expanded Nucleoside
NIH
2006-2009
Ring-Expanded Nucleosides as Therapeutic Agents
Nabi Biopharmaceuticals
1997-Present
"Fat" Nucleosides & Nucleotides
NIH
2002-2007
Novel Nucleoside Analogues as Potential Cancer Chemotherapeutics
Greebaum Cancer Center
2006-2007
Historical Record of Extramural Grant Support
$>10 Million
Various Agenecies (see below)
1983-Present

HISTORICAL RECORD OF EXTRAMURAL GRANT SUPPORT OF DR. HOSMANE (1983-PRESENT)

(Unless otherwise indicated, Dr. Hosmane is the PI)

 
(40) American Heart Association, Artificial Blood Based on Hemoglobin Dendrimers, 2007-09

(39) North American Biologicals, Inc. (Nabi) , Ring-Expanded Nucleosides & Nucleotides, 1997-09

(38) National Institutes of Health (NIAID, #R21AI071802), Mechanistic Studies of Anti-HIV Activity, 2006-08

(37) Greenbaum Cancer Center, UMB, Novel Nucleoside Analogs as Cancer Chemotherapeutics, 2006-07

(36) National Institutes of Health (NIAID, #R01AI55452), “Fat” Nucleosides & Nucleotides, 2002-07

(35) Grace Chemical Co., Synthesis of Novel Thiophene Analogues for Artificial Membranes, 2004-05

(34) National Institutes of Health (NHLBI, #R01HL48632), Novel Org. Reagents for Biomed. Appls, 1999-03

(33) National Institutes of Health (NHLBI, #R01HL48632-S1), Res. Suppl. Minority Undergrad. Asst., 2000-02

(32) Transbio Corp., Synthesis of a Novel Heterocycle for Sensitive Detn. of Proteins & Nucl. Acids, 2001-01

(31) Novadaq Corp., Canada, Synthesis of Indocyanine Green for Surgery in Opthamology, 2001-01

(30) National Institutes of Health ((NCI, #R01 CA71079),“Fat” & “Slim” Nucleosides & Nucleotides, 1996-00

(29) National Institutes of Health ((NCI, #R01 CA71079-S1), Res. Suppl. Minority Undergrad. Asst.,1997-00

(28) Maryland Industrial Partnership (MIPS #910.19), Nucleosides for Antiviral Activity, 1997-99

(27) National Science Foundation (Whalen, P. I.), High Field NMR Inter. Data Anal. & Modeling, 1996-98

(26) National Institutes of Health (NHLBI, #R01 HL33629), Novel Org. Reagents for Biomed. Appl., 1994-97

(25) Maryland Industrial Partnerships (MIPS #813.18), Stable Photochromic Compounds, 1994-96

(24) National Institutes of Health (NIGMS, #R01 GM49249), Novel Antiretroviral Nucleo(s/t)ides, 1992-96

(23) Boehringer-Mannheim Corp., Novel Heterocycles as Potential Therapeutic Agents, 1991-96

(22) National Institutes of Health (NIGMS, #R01 GM49249), Res. Suppl. Minority Grad. Asst., 1992-95

(21) Maryland Industrial Partnerships (MIPS, #1307.13), Novel Nucleosides for AIDS Therapy, 1992-95

(20) Rhone-Poulenc, Novel Heterocycles as Potential Agricultural Chemicals, 1991-95

(19) Maryland Industrial Partnerships (MIPS, #2001.27), Hemoglobin Blood Substitutes, 1991-94

(18) Martin-Marietta Laboratories, Synthesis of Photochromes for Holograms & Sensor Protection , 1993-94

(17) Autodesk, Inc., Design & Synthesis of Novel Organic Molecules for Biomedical Applications, 1992-93

(16) Burns Laboratories, Inc., Altered Nucleoside with Potential for AIDS Therapy, 1991-1993

(15) Burns Laboratories, Inc., Human Hemoglobin Cross-Linking Reagents, 1991-93

(14) National Institutes of Health (P.I. G. Rosen, UMB), Synthesis of Heterocyclic Spin Labels, 1990-92

(13) National Institutes of Health (NCI, #1R01 CA36154), “Fat” Nucleosides & Nucleotides, 1987-91

(12) Dow-Elanco Co., Novel Organics for Agricultural and Biomedical Applications, 1987-91

(11) Am. Cancer Soc.(MD Progr.), Is There a Correln bet. Conformn. & Activity of Nucleo(s/t)ides?, 1989-90

(10) Cytel Corporation, Biological Screening of Potential Immune Modulating Agents, 1989-90

(09) Monsanto Agricultural Co., Novel Heterocycles for Potential Agricultural Applications, 1989-94

(08) E. I. du Pont de Nemours & Co., Novel Het. Compds. as Potential Agricultural Chemicals, 1988-96

(07) American Heart Assoc., MD Affiliate, Inc., Synthetic Reagents to Cross-Link Hemoglobin, 1987-89

(06) Eli Lilly & Co., Novel Compounds for Potential Medicinal & Agricultural Applications, 1986-1993.

(05) National Institutes of Health (NHLBI, E. Bucci, P.I.), Hemoglobin-Based Oxygen Carriers, 1985-88

(04) Shell Development Company, Novel Compounds for Potential Agricultural Applications, 1985-86

(03) National Institutes of Health (NCI, #R01 CA36154), Synthetic Analogues of Coformycin, 1984-87

(02) Project SEED, Am. Chem. Soc., Summer Educational Experience for the Disadvantaged, 1983-00.

(01) Petroleum Research Fund, American Chemical Society, Total Synthesis of Coformycin, 1983-85